United States · Bill · HR
H.R. 5950 (117th)
Improving Patient Access to Care and Treatment Act
Introduced
12 November 2021
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Improving Patient Access to Care and Treatment Act This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 12 November 2021
Introduced in House (PDF)
Introduced in House · EN · 12 November 2021
Introduced in House
summary · EN · 12 November 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/5950
- Open data entity: https://api.congress.gov/v3/bill/117/hr/5950